Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

iSpecimen Inc. - Common Stock (ISPC)

0.1301
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 10th, 5:23 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.1301
Open-
Bid0.2229
Ask0.2230
Day's RangeN/A - N/A
52 Week Range0.1257 - 3.180
Volume74,398,229
Market Cap125.24K
PE Ratio (TTM)-0.0165
EPS (TTM)-7.9
Dividend & YieldN/A (N/A)
1 Month Average Volume22,227,798

Chart

About iSpecimen Inc. - Common Stock (ISPC)

Ispecimen Inc is a biotechnology company focused on enhancing the accessibility of biospecimens for research and clinical purposes. By leveraging advanced technology and an extensive network of biorepositories, Ispecimen facilitates the collection, management, and distribution of human biological samples, thereby accelerating medical research and development. Their platform aims to streamline the process for academia, pharmaceutical companies, and other organizations in need of high-quality biospecimens, ultimately contributing to advancements in personalized medicine and healthcare solutions. Read More

News & Press Releases

Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · April 9, 2026
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
Woburn, Massachusetts--(Newsfile Corp. - April 9, 2026) - iSpecimen (NASDAQ: ISPC), an online marketplace for human biospecimens, has implemented a...
Via Newsfile · April 9, 2026
On Tuesday, there are stocks with unusual volume. Let's take a look.chartmill.com
Via Chartmill · March 17, 2026
These stocks that are showing activity before the opening bell on Tuesday.chartmill.com
Via Chartmill · March 17, 2026
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
Woburn, Massachusetts--(Newsfile Corp. - March 16, 2026) - iSpecimen Inc. (NASDAQ: ISPC) (the "Company"), a leading provider of human biospecimens for research,...
Via Newsfile · March 16, 2026
Stocks Under $1: TOON, ISPC, CXAI, EONR to Watch Now
Investors searching for stocks under $1 with emerging catalysts are increasingly turning their attention to a mix of media, artificial intelligence, healthcare technology, and energy companies that are generating fresh news flow and operational developments. Among the names drawing attention are Kartoon Studios (NYSE American: TOON), iSpecimen Inc. (NASDAQ: ISPC) , CXApp Inc. (NASDAQ: CXAI) , and EON Resources Inc. (NYSE American: EONR) —companies operating across sectors where innovation and industry demand continue to evolve.
Via AB Newswire · March 13, 2026
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Via Chartmill · March 13, 2026
These stocks are making the most noise in today's session.chartmill.com
Via Chartmill · March 13, 2026
Which stocks are experiencing notable movement on Friday?chartmill.com
Via Chartmill · March 13, 2026
Friday's session: gap up and gap down stockschartmill.com
Via Chartmill · March 13, 2026
These stocks that are showing activity before the opening bell on Friday.chartmill.com
Via Chartmill · March 13, 2026
Which stocks are moving after the closing bell on Thursday?chartmill.com
Via Chartmill · March 12, 2026
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
Woburn, Massachusetts--(Newsfile Corp. - March 12, 2026) - iSpecimen Inc. (NASDAQ: ISPC) (the "Company"), a leading technology marketplace connecting researchers with biospecimen...
Via Newsfile · March 12, 2026
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
Strengthens iSpecimen’s next-generation marketplace platform
By iSpecimen Inc. · Via GlobeNewswire · March 12, 2026
Curious about the stocks that are showing activity after the closing bell on Thursday?chartmill.com
Via Chartmill · February 19, 2026
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete
Woburn, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ: ISPC) today announced the successful completion of Milestone 2,...
Via Newsfile · February 6, 2026
Get insights into the top gainers and losers of Friday's pre-market session.chartmill.com
Via Chartmill · February 6, 2026
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
Lexington, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ: ISPC), a leading provider of human biospecimens for research,...
Via Newsfile · February 6, 2026
Wondering what's happening in today's after-hours session?chartmill.com
Via Chartmill · January 5, 2026
Here are the top movers in Wednesday's session.chartmill.com
Via Chartmill · December 31, 2025
Unusual volume stocks in Wednesday's sessionchartmill.com
Via Chartmill · December 31, 2025
Get insights into the top gainers and losers of Wednesday's pre-market session.chartmill.com
Via Chartmill · December 31, 2025
iSpecimen Stock Surges 60% After Hours Off A Record Low — What Triggered The Turn?stocktwits.com
Shares rebounded sharply after the company disclosed fresh capital-raising plans following a steep selloff.
Via Stocktwits · December 30, 2025
What's going on in today's after hours sessionchartmill.com
Via Chartmill · December 30, 2025
iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement
WOBURN, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it entered into a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $5.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company.
By iSpecimen Inc. · Via GlobeNewswire · December 30, 2025